Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012183696> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3012183696 endingPage "58" @default.
- W3012183696 startingPage "52" @default.
- W3012183696 abstract "Immune checkpoint inhibitors are a cornerstone in the management of many oncological disorders, and their indications continue to grow. However, as with any therapy we must remain vigilant of the possible adverse effects. Although interstitial nephritis is a reported cause of immune checkpoint inhibitor–related kidney injury, immune-mediated glomerular disease has rarely been described. Here, we present three patients being treated with checkpoint inhibitors for colon cancer, metastatic squamous cell carcinoma of the lung, and melanoma, who developed biopsy-proven amyloid A amyloidosis. In all three cases, the malignancies were in remission, yet continued inflammation and amyloid deposition occurred, pointing toward a primary role of the immune checkpoint inhibitor. Treatment generally remains a challenge due to a paucity of reported cases, thus further study of cytokine profile is prudent. In one case, the patient was given tocilizumab in the setting of elevated interleukin-6 levels; unfortunately no appreciable renal benefit was noted and the patient became dialysis dependent. In the other two cases, the patients were treated with colchicine and steroids. One patient had a substantial decrease in proteinuria and inflammatory markers while no significant response was noted in the other. Knowledge of immune checkpoint inhibitor–associated amyloid A amyloidosis is important for the oncologist and the nephrologists." @default.
- W3012183696 created "2020-03-23" @default.
- W3012183696 creator A5018399640 @default.
- W3012183696 creator A5018442992 @default.
- W3012183696 creator A5027528681 @default.
- W3012183696 creator A5046393021 @default.
- W3012183696 creator A5049148114 @default.
- W3012183696 creator A5054378441 @default.
- W3012183696 creator A5071960073 @default.
- W3012183696 date "2020-02-01" @default.
- W3012183696 modified "2023-09-30" @default.
- W3012183696 title "Immune checkpoint inhibitor–associated renal amyloid A amyloidosis: A case series and review of the literature" @default.
- W3012183696 cites W2087539494 @default.
- W3012183696 cites W2155947834 @default.
- W3012183696 cites W2167328524 @default.
- W3012183696 cites W2345522085 @default.
- W3012183696 cites W2413514895 @default.
- W3012183696 cites W2572174216 @default.
- W3012183696 cites W2722553159 @default.
- W3012183696 cites W2752227448 @default.
- W3012183696 cites W2783137027 @default.
- W3012183696 cites W2914287567 @default.
- W3012183696 cites W2943820705 @default.
- W3012183696 cites W4238737965 @default.
- W3012183696 cites W4243640334 @default.
- W3012183696 doi "https://doi.org/10.1177/2399369320907598" @default.
- W3012183696 hasPublicationYear "2020" @default.
- W3012183696 type Work @default.
- W3012183696 sameAs 3012183696 @default.
- W3012183696 citedByCount "9" @default.
- W3012183696 countsByYear W30121836962021 @default.
- W3012183696 countsByYear W30121836962022 @default.
- W3012183696 countsByYear W30121836962023 @default.
- W3012183696 crossrefType "journal-article" @default.
- W3012183696 hasAuthorship W3012183696A5018399640 @default.
- W3012183696 hasAuthorship W3012183696A5018442992 @default.
- W3012183696 hasAuthorship W3012183696A5027528681 @default.
- W3012183696 hasAuthorship W3012183696A5046393021 @default.
- W3012183696 hasAuthorship W3012183696A5049148114 @default.
- W3012183696 hasAuthorship W3012183696A5054378441 @default.
- W3012183696 hasAuthorship W3012183696A5071960073 @default.
- W3012183696 hasConcept C121608353 @default.
- W3012183696 hasConcept C126322002 @default.
- W3012183696 hasConcept C203014093 @default.
- W3012183696 hasConcept C2777701055 @default.
- W3012183696 hasConcept C2779951007 @default.
- W3012183696 hasConcept C2780030458 @default.
- W3012183696 hasConcept C2780472472 @default.
- W3012183696 hasConcept C2780851360 @default.
- W3012183696 hasConcept C71924100 @default.
- W3012183696 hasConceptScore W3012183696C121608353 @default.
- W3012183696 hasConceptScore W3012183696C126322002 @default.
- W3012183696 hasConceptScore W3012183696C203014093 @default.
- W3012183696 hasConceptScore W3012183696C2777701055 @default.
- W3012183696 hasConceptScore W3012183696C2779951007 @default.
- W3012183696 hasConceptScore W3012183696C2780030458 @default.
- W3012183696 hasConceptScore W3012183696C2780472472 @default.
- W3012183696 hasConceptScore W3012183696C2780851360 @default.
- W3012183696 hasConceptScore W3012183696C71924100 @default.
- W3012183696 hasIssue "1-2" @default.
- W3012183696 hasLocation W30121836961 @default.
- W3012183696 hasOpenAccess W3012183696 @default.
- W3012183696 hasPrimaryLocation W30121836961 @default.
- W3012183696 hasRelatedWork W1966468687 @default.
- W3012183696 hasRelatedWork W2325455529 @default.
- W3012183696 hasRelatedWork W2346089412 @default.
- W3012183696 hasRelatedWork W2384360564 @default.
- W3012183696 hasRelatedWork W2497036303 @default.
- W3012183696 hasRelatedWork W2906311539 @default.
- W3012183696 hasRelatedWork W3007491672 @default.
- W3012183696 hasRelatedWork W4233251381 @default.
- W3012183696 hasRelatedWork W4307935062 @default.
- W3012183696 hasRelatedWork W4323544154 @default.
- W3012183696 hasVolume "4" @default.
- W3012183696 isParatext "false" @default.
- W3012183696 isRetracted "false" @default.
- W3012183696 magId "3012183696" @default.
- W3012183696 workType "article" @default.